Literature DB >> 23044261

Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry.

Ginger L Milne1, Benlian Gao, Erin S Terry, William E Zackert, Stephanie C Sanchez.   

Abstract

F2-Isoprostanes (IsoPs) are isomers of prostaglandin F2α formed from the nonenzymatic free radical-catalyzed peroxidation of arachidonic acid. Since discovery of these molecules by Morrow and Roberts in 1990, F2-IsoPs have been shown to be excellent biomarkers as well as potent mediators of oxidative stress in vivo in humans. Isofurans (IsoFs) are also oxidation products generated from the nonenzymatic oxidation of arachidonic acid. IsoFs are preferentially formed instead of F2-IsoPs in settings of increased oxygen tension. The protocol presented herein is the current methodology that our laboratory uses to quantify F2-IsoPs and IsoFs in biological tissues and fluids using gas chromatography/mass spectrometry (GC/MS). A variety of analytical procedures to measure F2-IsoPs, including other GC/MS methods and liquid chromatography/MS and immunological approaches, are reported in the literature. This method provides a very low limit of quantitation and is suitable for analysis of both F2-IsoPs and IsoFs from a variety of biological sources including urine, plasma, tissues, cerebral spinal fluid, exhaled breath condensate, and amniotic fluid, among others.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044261      PMCID: PMC4306329          DOI: 10.1016/j.freeradbiomed.2012.09.030

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  33 in total

1.  Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Authors:  M B Kadiiska; B C Gladen; D D Baird; D Germolec; L B Graham; C E Parker; A Nyska; J T Wachsman; B N Ames; S Basu; N Brot; G A Fitzgerald; R A Floyd; M George; J W Heinecke; G E Hatch; K Hensley; J A Lawson; L J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; M K Shigenaga; R S Sohal; J Sun; R R Tice; D H Van Thiel; D Wellner; P B Walter; K B Tomer; R P Mason; J C Barrett
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

2.  Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method.

Authors:  Wen-Liang Song; John A Lawson; Miao Wang; Helen Zou; Garret A FitzGerald
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

Review 3.  New insights regarding the autoxidation of polyunsaturated fatty acids.

Authors:  Huiyong Yin; Ned A Porter
Journal:  Antioxid Redox Signal       Date:  2005 Jan-Feb       Impact factor: 8.401

4.  Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.

Authors:  L J Roberts; K P Moore; W E Zackert; J A Oates; J D Morrow
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

5.  Nomenclature of isoprostanes: a proposal.

Authors:  J Rokach; S P Khanapure; S W Hwang; M Adiyaman; J A Lawson; G A FitzGerald
Journal:  Prostaglandins       Date:  1997-12

6.  Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane.

Authors:  Dora Il'yasova; Jason D Morrow; Anastasia Ivanova; Lynne E Wagenknecht
Journal:  Ann Epidemiol       Date:  2004-11       Impact factor: 3.797

7.  A nomenclature system for the isoprostanes.

Authors:  D F Taber; J D Morrow; L J Roberts
Journal:  Prostaglandins       Date:  1997-02

8.  Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry.

Authors:  Chung-Yung J Lee; Andrew M Jenner; Barry Halliwell
Journal:  Biochem Biophys Res Commun       Date:  2004-07-30       Impact factor: 3.575

9.  Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.

Authors:  J D Morrow; J A Awad; H J Boss; I A Blair; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  A nomenclature system for isofurans.

Authors:  Douglass F Taber; Joshua P Fessel; L Jackson Roberts
Journal:  Prostaglandins Other Lipid Mediat       Date:  2004-01       Impact factor: 3.072

View more
  50 in total

Review 1.  Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology.

Authors:  Corinne M Spickett; Andrew R Pitt
Journal:  Antioxid Redox Signal       Date:  2015-03-26       Impact factor: 8.401

2.  Adrenic acid non-enzymatic peroxidation products in biofluids of moderate preterm infants.

Authors:  Ángel Sánchez-Illana; Vidhi Shah; José David Piñeiro-Ramos; Juliann M Di Fiore; Guillermo Quintás; Thomas M Raffay; Peter M MacFarlane; Richard J Martin; Julia Kuligowski
Journal:  Free Radic Biol Med       Date:  2019-02-25       Impact factor: 7.376

3.  Feline urinary F2-isoprostanes measured by enzyme-linked immunoassay and gas chromatography-mass spectroscopy are poorly correlated.

Authors:  Andrew D Woolcock; Ashley Leisering; Pierre Deshuillers; Janet Roque-Torres; George E Moore
Journal:  J Vet Diagn Invest       Date:  2020-07-05       Impact factor: 1.279

4.  Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

Authors:  Matthew B Rivara; Catherine K Yeung; Cassianne Robinson-Cohen; Brian R Phillips; John Ruzinski; Denise Rock; Lori Linke; Danny D Shen; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Am J Kidney Dis       Date:  2016-12-04       Impact factor: 8.860

5.  Oxidative Stress and Breast Cancer Risk in Premenopausal Women.

Authors:  Hazel B Nichols; Chelsea Anderson; Alexandra J White; Ginger L Milne; Dale P Sandler
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

6.  Tea consumption and oxidative stress: a cross-sectional analysis of 889 premenopausal women from the Sister Study.

Authors:  Dongyu Zhang; Kelly Ferguson; Melissa Troester; Jeannette T Bensen; Jianwen Cai; Ginger L Milne; Dale P Sandler; Hazel B Nichols
Journal:  Br J Nutr       Date:  2018-12-20       Impact factor: 3.718

7.  Assessing Human Health Risk to Endocrine Disrupting Chemicals: a Focus on Prenatal Exposures and Oxidative Stress.

Authors:  Kari Neier; Elizabeth H Marchlewicz; Dana C Dolinoy; Vasantha Padmanabhan
Journal:  Endocr Disruptors (Austin)       Date:  2015-07-28

8.  Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury.

Authors:  Nataliya I Skrypnyk; Paul Voziyan; Haichun Yang; Christian R de Caestecker; Marie-Claude Theberge; Mathieu Drouin; Billy Hudson; Raymond C Harris; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

9.  Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.

Authors:  Danielle L Kirkman; Bryce J Muth; Meghan G Ramick; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

10.  Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Authors:  Sherry L Spinelli; Katie L Lannan; Ann E Casey; Amanda Croasdell; Timothy M Curran; Kelly F Henrichs; Stephen J Pollock; Ginger A Milne; Majed A Refaai; Charles W Francis; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2013-11-05       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.